NCT03739268View on ClinicalTrials.gov

GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

September 3, 2020

Study Completion Date

September 1, 2021

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Sevelamer

Sevelamer powder dissolved in water 1,600 mg three times a day for 17 days

DRUG

Placebo

placebo powder dissolved in water 1,600 mg three times a day for 17 days

Trial Locations (1)

2900

Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Steno Diabetes Center Copenhagen

OTHER